JPRN-UMIN000050219已完成Unknown
Confirmatory study of the efficacy and effectiveness of egg consumption on cognitive function improvement in Japanese adults - A placebo-controlled, double-blind, randomized, comparative trial-. - Confirmatory study of the efficacy and effectiveness of egg consumption on cognitive function improvement in Japanese adults.
IMEQRD Co., Ltd0 个研究点目标入组 100 人开始时间: 2023年2月7日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 55years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Taking foods or dietary supplements with functional health claims that may affect the outcome of the study, such as FOSHU, and FFC, more than three times per week and are unable to discontinue taking these foods after the time of consent. 2.Are regularly taking medications that may affect the outcome of the study, such as antibiotics, bowel preparations, laxatives, and medications for psychiatric disorders, and are unable to limit the use of these medications after the time of consent. 3.Are diagnosed with lipidemia, and receive treatment. 4.Are diagnosed with dementia, and receive treatment. 5.Heavy drinker, greater than or equal to 60 grams of alcohol per day. 6.Have irregular eating habits or rhythm of daily life. 7.Have intense regular exercise habits. 8.Voluntarily take bluefish such as sardines, mackerel, and saury. 9.Have an egg intake amount greater than or equal to 14 per week in daily life. 10.Daily use of brain-training materials that may affect cognitive function, such as devices, digital applications, or games. 11.Serious heart, liver, renal, or gastrointestinal disease or a history of such disease. 12.Allergies to any medications or foods. 13.Are currently participating in other clinical trials, plan to participate in other clinical trials three months after the end of the study, plan to participate in other clinical trials after consenting to the study, and experienced the Cognitrax six months before consenting to the study. 14.Have donated more than 200 mL of blood within one month before the start of the study. 15.Have a blood donation volume greater than 1200 mL, which is the sum of the planned blood donation volume in the study and the previous blood donation volume within 12 months before the start of the study. 16.Unsuitable for the study, as determined by the investigator.
研究者
相似试验
招募中
2 期
A Expoloratory Study to evaluate the Efficacy and Safety of Hydrocortisone for the Prevention of Symptomatic Vasospasm after Subarachnoid Hemorrhage.Patients with subarachnoid hemorrhage due to cerebral aneurysm rupturesubarachnoid hemorrhage, symptomatic vasospasm, hydrocortisoneJPRN-jRCTs051230153ozumi Yoichi100
进行中（未招募）
不适用
A study to investigate belimumab for the treatment of chronic immune thrombocytopeniaChronic Immune ThrombocytopeniaMedDRA version: 15.1Level: LLTClassification code 10051057Term: Idiopathic thrombocytopeniaSystem Organ Class: 100000004851EUCTR2011-000241-21-DEGlaxoSmithKline Research & Development Limited40
进行中（未招募）
不适用
A study to investigate belimumab for the treatment of chronic immune thrombocytopeniaChronic Immune ThrombocytopeniaMedDRA version: 14.1Level: LLTClassification code 10051057Term: Idiopathic thrombocytopeniaSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2011-000241-21-GBGlaxoSmithKline Research & Development Limited40
招募中
3 期
A confirmatory study of TRM-270 in comparison with Seprafilm in patients with rectal cancer receiving surgeryRectal cancerJPRN-jRCT2032220451Tomita Shinpei260
已完成
2 期
Prospective study of evaluating the efficacy and safety of Radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastasescastration-resistant prostate cancer with bone metastasesJPRN-UMIN000023897ational Hospital Organization Saitama Hospital20